Company: CWAN
Filing Date: 2025-03-06
Form Type: S-4/A
Source: 0001193125-25-048570
Chunk: 8

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-03-06
Form: S-4/A
Chunk 8
---
 Statement/Prospectus carefully before voting. In particular, see the section titled “Risk Factors.” The board of directors of Enfusion (the “ Enfusion Board”) unanimously (i) determined that the Merger Agreement, the Mergers and the other transactions contemplated by the Merger Agreement (the “ Transactions”) are advisable, fair to and in the best interests of Enfusion and Enfusion Stockholders, (ii) adopted and approved the Merger Agreement, the Mergers and the other Transactions, (iii) directed that the Merger Agreement be submitted to Enfusion Stockholders entitled to vote thereon for adoption thereby and (iv) resolved to recommend that such Enfusion Stockholders adopt the Merger Agreement and approve the Transactions, including the Mergers. The Enfusion Board unanimously recommends that Enfusion Stockholders vote “FOR” the Merger Agreement Proposal and “FOR” the Adjournment Proposal. The Enfusion Board has fixed the close of business on , 2025 as the record date for determination of Enfusion Stockholders entitled to receive notice of, and to vote at, the Special Meeting or any adjournments or postponements thereof. Only holders of record of Enfusion Class A common stock (“ Enfusion Common Stock”) and Enfusion Class B common stock (“ Enfusion Class B Common Stock”) as of the close of business on the record date are entitled to receive notice of, and to vote at, the Special Meeting. i

YOUR VOTE IS VERY IMPORTANT, REGARDLESS OF THE NUMBER OF SHARES THAT YOU OWN.

The transactions cannot be completed unless the Merger Agreement Proposal is approved by the affirmative vote, virtually or by proxy, of
holders of at least a majority of the outstanding shares of Enfusion Common Stock and Enfusion Class B Common Stock entitled to vote thereon.

Further, the affirmative vote, virtually or by proxy, of a majority of the votes properly cast for or against the Adjournment Proposal by
holders of shares of Enfusion Common Stock and Enfusion Class B Common Stock represented at the Special Meeting is required to approve the Adjournment Proposal.

Whether or not you expect to participate in the Special Meeting, Enfusion urges you to submit a proxy to have your shares voted as promptly as possible either: (1)via the Internet at (see proxy card for instructions); (2) by telephone (see proxy card for instructions); or (3)by completing, signing and returning the enclosed proxy card in the postage-paid envelope provided, so that your shares may be represented and